There were 1,645 press releases posted in the last 24 hours and 414,064 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Studies on Australian Chronic Kidney Disease therapy DMX-200 expanded following compelling Phase 2 trial outcomes

TO:
Ilona Marchetta
IR Department
+61 416 156 136

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image